Maribel G. Vallespí - Search Results

Year	Number of Results
2003	2
2004	1
2010	2
2011	1
2013	1
2014	1
2016	1
2017	1
2018	1
2019	1
2021	1
2024	0

1

A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.

Vallespi MG, Mestre B, Marrero MA, Uranga R, Rey D, Lugiollo M, Betancourt M, Silva K, Corrales D, Lamadrid Y, Rodriguez Y, Maceo A, Chaviano PP, Lemos G, Cabrales A, Freyre FM, Santana H, Garay HE, Oliva B, Fernandez JR. Vallespi MG, et al. Int J Cancer. 2021 Sep 15;149(6):1313-1321. doi: 10.1002/ijc.33695. Epub 2021 May 27. Int J Cancer. 2021. PMID: 34019700 Free article. Clinical Trial.

2

Generation of stable reporter breast and lung cancer cell lines for NF-κB activation studies.

Daghero H, Pagotto R, Vallespí MG, Bollati-Fogolín M. Daghero H, et al. Among authors: vallespi mg. J Biotechnol. 2019 Aug 10;301:79-87. doi: 10.1016/j.jbiotec.2019.05.014. Epub 2019 May 27. J Biotechnol. 2019. PMID: 31145935

3

Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552.

Astrada S, Gomez Y, Barrera E, Obal G, Pritsch O, Pantano S, Vallespí MG, Bollati-Fogolín M. Astrada S, et al. Among authors: vallespi mg. J Pept Sci. 2016 Nov;22(11-12):711-722. doi: 10.1002/psc.2934. J Pept Sci. 2016. PMID: 27933724

4

The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.

Fernández Massó JR, Oliva Argüelles B, Tejeda Y, Astrada S, Garay H, Reyes O, Delgado-Roche L, Bollati-Fogolín M, Vallespí MG. Fernández Massó JR, et al. Among authors: vallespi mg. J Amino Acids. 2013;2013:251398. doi: 10.1155/2013/251398. Epub 2013 Jan 16. J Amino Acids. 2013. PMID: 23401744 Free PMC article.

5

Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.

Vallespí MG, Pimentel G, Cabrales-Rico A, Garza J, Oliva B, Mendoza O, Gomez Y, Basaco T, Sánchez I, Calderón C, Rodriguez JC, Markelova MR, Fichtner I, Astrada S, Bollati-Fogolín M, Garay HE, Reyes O. Vallespí MG, et al. J Pept Sci. 2014 Nov;20(11):850-9. doi: 10.1002/psc.2676. Epub 2014 Jul 20. J Pept Sci. 2014. PMID: 25044757

6

Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity.

Astrada S, Fernández Massó JR, Vallespí MG, Bollati-Fogolín M. Astrada S, et al. Among authors: vallespi mg. Molecules. 2018 Mar 30;23(4):801. doi: 10.3390/molecules23040801. Molecules. 2018. PMID: 29601540 Free PMC article.

7

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.

Vallespi MG, Fernandez JR, Torrens I, Garcia I, Garay H, Mendoza O, Granadillo M, Falcon V, Acevedo B, Ubieta R, Guillen GE, Reyes O. Vallespi MG, et al. J Pept Sci. 2010 Jan;16(1):40-7. doi: 10.1002/psc.1192. J Pept Sci. 2010. PMID: 19908203

8

Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.

Araña Mde J, Vallespi MG, Chinea G, Vallespi GV, Rodriguez-Alonso I, Garay HE, Buurman WA, Reyes O. Araña Mde J, et al. Among authors: vallespi mg. J Endotoxin Res. 2003;9(5):281-91. doi: 10.1179/096805103225002520. J Endotoxin Res. 2003. PMID: 14577844

9

The first report of cases of pet dogs with naturally occurring cancer treated with the antitumor peptide CIGB-552.

Vallespi MG, Rodriguez JC, Seoane LC, Alvarez P, Santana H, Garay H, Cabrera IA, Espinosa JT, Reyes O. Vallespi MG, et al. Res Vet Sci. 2017 Oct;114:502-510. doi: 10.1016/j.rvsc.2017.09.029. Epub 2017 Sep 29. Res Vet Sci. 2017. PMID: 28987957

10

Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in Gram-positive sepsis.

Vallespi MG, Colas M, Garay H, Reyes O, Araña MJ. Vallespi MG, et al. Int Immunopharmacol. 2004 Oct;4(10-11):1343-51. doi: 10.1016/j.intimp.2004.05.019. Int Immunopharmacol. 2004. PMID: 15313432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year